SKFB:GETTEXSKF AB Class B Analysis
Data as of 2026-03-14 - not real-time
€21.08
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
AB SKF is trading at €21.08, essentially hugging its calculated support level and sitting almost flat between the 20‑day and 50‑day SMAs, which signals a short‑term consolidation zone. Technical momentum is mixed: the RSI of roughly 33 suggests the stock is oversold, while the MACD histogram remains negative, indicating lingering bearish pressure. Volatility is elevated at over 37% annualized and the recent max drawdown approaches 30%, underscoring a fairly turbulent price environment. On the upside, the dividend yield stands at 3.33% with a payout ratio near 90%, offering an attractive cash return despite the high distribution level. The DCF fair‑value estimate of about €285 vastly exceeds the current price, pointing to a deep valuation gap. Fundamental metrics show solid free cash flow generation and a modest ROE, but a debt‑to‑equity ratio above 27 raises a note of caution.
Given the pronounced undervaluation, the dividend appeal, and the oversold technical reading, the stock presents a compelling entry point for value‑oriented investors. However, the combination of high volatility, limited trading volume, and a near‑full payout ratio tempers the upside, suggesting a measured buying stance with attention to liquidity constraints. The industrial sector backdrop is stable, yet regulatory and geographic exposures remain modest, reinforcing the view that the primary risks are market‑driven rather than company‑specific.
Given the pronounced undervaluation, the dividend appeal, and the oversold technical reading, the stock presents a compelling entry point for value‑oriented investors. However, the combination of high volatility, limited trading volume, and a near‑full payout ratio tempers the upside, suggesting a measured buying stance with attention to liquidity constraints. The industrial sector backdrop is stable, yet regulatory and geographic exposures remain modest, reinforcing the view that the primary risks are market‑driven rather than company‑specific.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with oversold RSI
- Deep valuation discount to DCF fair value
- Attractive dividend yield despite high payout
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Elevated volatility and liquidity constraints
- Mixed MACD signals indicating uncertain momentum
- Continued dividend income offset by payout sustainability concerns
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Fundamental cash‑flow strength and low beta
- Sustained industrial demand across multiple end‑markets
- Long‑term upside potential if market re‑prices the valuation gap
Key Metrics & Analysis
Financial Health
Revenue Growth-11.10%
Profit Margin4.29%
P/E Ratio26.0
ROE7.22%
ROA3.95%
Debt/Equity27.56
P/B Ratio0.2
Free Cash Flow€9.8B
Industry P/E29.1
Technical Analysis
TrendBullish
RSI33.3
Support€21.08
Resistance€24.46
MA 20€23.13
MA 50€23.13
MA 200€21.60
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value€285.70
GradeUndervalued
TypeValue
Dividend Yield3.33%
Risk Assessment
Beta0.56
Volatility37.29%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.